No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
BofA Securities Maintains Vir Biotechnology(VIR.US) With Hold Rating, Cuts Target Price to $12
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (VIR) and Belite Bio, Inc. ADR (BLTE)
Needham Maintains Vir Biotechnology(VIR.US) With Buy Rating, Cuts Target Price to $14
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Needham Maintains Buy on Vir Biotechnology, Lowers Price Target to $14
Vir Biotechnology Analyst Ratings